Goal-directed Hemodynamic Management and Acute Kidney Injury After Radical Nephrectomy
Impact of Goal-directed Hemodynamic Management on the Incidence of Acute Kidney Injury and Long-term Outcomes in Patients Undergoing Radical Nephrectomy: A Randomized Clinical Trial
調査の概要
状態
詳細な説明
Renal cancer accounts for 20.3% of urinary system tumors, and the incidence is still increasing. Surgical resection is the main treatment of renal cancer; radical nephrectomy is the standard operation. Acute kidney injury (AKI) is a common complication after radical nephrectomy, with an incidence of up to 53.9%. AKI is associated with the development of chronic kidney disease (CKD) and is an independent risk factor of new onset CKD in patients without underlying kidney disease. A meta-analysis showed that one year after surgery, patients with AKI had a 2.7-fold increased risk of new onset or progression of CKD and a 4.8-fold increased risk of end-stage renal disease. Moreover, even mild AKI is associated with renal insufficiency 1-2 years after surgery. Taking active measures to reduce the incidence of AKI may improve long-term renal function after radical nephrectomy.
Many clinical studies show that intraoperative hypotension is an important risk factor of postoperative kidney injury. For example, a study found that intraoperative mean arterial pressure (MAP) <65 mmHg or a decrease of more than 20% from baseline was associated with an increased risk of postoperative AKI; the risk of AKI increased alone with prolonged duration of hypotension. A recent randomized controlled trial showed that, compared with routine intraoperative blood pressure management, goal-directed hemodynamic management reduced the incidence of organ injury from 63.4% to 46.3% within 30 days after surgery. A meta-analysis included 65 randomized controlled trials with 9308 patients and observed the effect of goal-directed hemodynamic management on postoperative AKI. The results showed that a combination of fluid therapy with vasopressors reduced the incidence of AKI in high-risk patients following major abdominal or orthopedic surgery.
In a previous pilot trial of the authors, goal-directed hemodynamic management reduced the incidence of AKI by about 40% in patients following partial nephrectomy. However, the difference was not statistically significant due to insufficient sample size. The purpose of this trial is to investigate whether goal-directed intraoperative hemodynamic management can reduce the incidence of acute kidney injury in patients undergoing radical nephrectomy.
研究の種類
入学 (予想される)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Dong-Xin Wang, MD,PhD
- 電話番号:86 10 83572784
- メール:wangdongxin@hotmail.com
研究連絡先のバックアップ
- 名前:Yi Zhao, MD
- 電話番号:86 10 83572460
- メール:sunnyzy316@163.com
研究場所
-
-
Beijing
-
Beijing、Beijing、中国、100034
- Beijing University First Hospital
-
コンタクト:
- Dong-Xin Wang, MD, PHD
- 電話番号:86 10 83572784
- メール:wangdongxin@hotmail.com
-
コンタクト:
- Yi Zhao, MD
- 電話番号:+861083572460
- メール:sunnyzy316@163.com
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion criteria:
- Age of 18 years or older;
- Scheduled to undergo radical nephrectomy for renal cancer.
Exclusion criteria
- Refused to participate;
- Diagnosed with chronic kidney disease (stage 3 or higher) before surgery;
- Uncontrolled severe hypertension (systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg);
- Unable to communicate due to severe dementia, language barrier, or end-stage disease before surgery;
- Enrolled in other trials;
- Other conditions that are considered unsuitable for inclusion (specific reasons should be indicated).
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:トリプル
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
実験的:Targeted blood pressure management
During anesthesia, mean blood pressure is maintained ≥85 mmHg or above baseline by combining fluid challenge and norepinephrine infusion; For patients admitted to intensive care unit after surgery, mean blood pressure is maintained ≥85 mmHg or above baseline by combining fluid challenge and norepinephrine infusion; In the general ward, systolic blood pressure is maintained ≥110 mmHg or within 10% of baseline by delaying antihypertensive resumption, providing fluid challenge, and/or norepinephrine infusion. |
During anesthesia, mean blood pressure is maintained ≥85 mmHg or above baseline by combining fluid challenge and norepinephrine infusion; For patients admitted to intensive care unit after surgery, mean blood pressure is maintained ≥85 mmHg or above baseline by combining fluid challenge and norepinephrine infusion; In the general ward, systolic blood pressure is maintained ≥110 mmHg or within 10% of baseline by delaying antihypertensive resumption, providing fluid challenge, and/or norepinephrine infusion. |
アクティブコンパレータ:Routine care
During anesthesia, mean blood pressure is maintained ≥65 mmHg or within 20% of baseline according to routine practice; For patients admitted to intensive care unit, mean blood pressure is maintained ≥65 mmHg or within 20% of baseline according to routine practice; In the general ward, management is performed according to routine practice. |
In the general ward, management is performed according to routine practice.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Incidence of acute kidney injury
時間枠:Up to 3 days after surgery
|
Acute kidney injury is diagnosed according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria.
|
Up to 3 days after surgery
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
手術後の入院期間
時間枠:手術後30日まで
|
手術後の入院期間
|
手術後30日まで
|
Classification of acute kidney injury
時間枠:Up to 3 days after surgery
|
Classification of acute kidney injury is diagnosed according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria.
|
Up to 3 days after surgery
|
Proportion of intensive care unit after surgery
時間枠:Up to 30 days after surgery
|
Proportion of intensive care unit after surgery
|
Up to 30 days after surgery
|
Incidence of postoperative complications
時間枠:Up to 30 days after surgery
|
Postoperative complications are defined as new-onset medical conditions that are harmful to patients' recovery and required therapeutic intervention, i.e., grade 2 or higher on the Clavien-Dindo classification.
|
Up to 30 days after surgery
|
Chronic kidney disease free survival time
時間枠:Up to 3 years after surgery
|
Time interval from the end of surgery to new onset of chronic kidney disease (stage 3 or above) or all-cause death, which ever come first.
Chronic kidney disease is defined as glomerular filtration rate <60 ml/min/1.73
m2.
|
Up to 3 years after surgery
|
Event free survival
時間枠:Up to 3 years after surgery
|
Time interval from the end of surgery to new-onset chronic kidney disease (stage 3 or above), serious events (required hospitalization or reoperation), or all-cause death, which ever come first.
|
Up to 3 years after surgery
|
Overall survival time
時間枠:Up to 3 years after surgery
|
Time interval from the end of surgery to all-cause death.
|
Up to 3 years after surgery
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Quality of life of survivors at 1, 2, and 3 years after surgery
時間枠:Up to 3 years after surgery
|
Quality of life is assessed with the World Health Organization Quality of Life brief version (WHOQOL-BREF).
This is a 24-item questionnaire that assesses the quality of life in physical, psychological, and social relationship, and environmental domains.
The score ranges from 0 to 100 for each domain, with higher score indicating better function.
|
Up to 3 years after surgery
|
Proportion of intensive care unit admission with endotracheal intubation
時間枠:Up to 30 days after surgery
|
Proportion of intensive care unit admission with endotracheal intubation
|
Up to 30 days after surgery
|
Length of stay in intensive care unit after surgery
時間枠:Up to 30 days after surgery
|
Length of stay in intensive care unit after surgery
|
Up to 30 days after surgery
|
Pain severity after surgery
時間枠:UP to 3 days after surgery
|
Pain severity is assessed with the numeric rating scale.
This is a 11-point scale with 0= no pain and 10=the worst pain.
|
UP to 3 days after surgery
|
協力者と研究者
出版物と役立つリンク
一般刊行物
- Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
- Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, Cywinski J, Thabane L, Sessler DI. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013 Sep;119(3):507-15. doi: 10.1097/ALN.0b013e3182a10e26.
- See EJ, Jayasinghe K, Glassford N, Bailey M, Johnson DW, Polkinghorne KR, Toussaint ND, Bellomo R. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int. 2019 Jan;95(1):160-172. doi: 10.1016/j.kint.2018.08.036. Epub 2018 Nov 23.
- Monk TG, Bronsert MR, Henderson WG, Mangione MP, Sum-Ping ST, Bentt DR, Nguyen JD, Richman JS, Meguid RA, Hammermeister KE. Association between Intraoperative Hypotension and Hypertension and 30-day Postoperative Mortality in Noncardiac Surgery. Anesthesiology. 2015 Aug;123(2):307-19. doi: 10.1097/ALN.0000000000000756. Erratum In: Anesthesiology. 2016 Mar;124(3):741-2.
- Sun LY, Wijeysundera DN, Tait GA, Beattie WS. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015 Sep;123(3):515-23. doi: 10.1097/ALN.0000000000000765.
- Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth. 2018 Oct;121(4):706-721. doi: 10.1016/j.bja.2018.04.036. Epub 2018 Jun 20.
- Futier E, Lefrant JY, Guinot PG, Godet T, Lorne E, Cuvillon P, Bertran S, Leone M, Pastene B, Piriou V, Molliex S, Albanese J, Julia JM, Tavernier B, Imhoff E, Bazin JE, Constantin JM, Pereira B, Jaber S; INPRESS Study Group. Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial. JAMA. 2017 Oct 10;318(14):1346-1357. doi: 10.1001/jama.2017.14172.
- Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038. Epub 2018 Aug 25. No abstract available.
- Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179-84. doi: 10.1159/000339789. Epub 2012 Aug 7. No abstract available.
- Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009 May 5;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006. Erratum In: Ann Intern Med. 2011 Sep 20;155(6):408.
- Salmasi V, Maheshwari K, Yang D, Mascha EJ, Singh A, Sessler DI, Kurz A. Relationship between Intraoperative Hypotension, Defined by Either Reduction from Baseline or Absolute Thresholds, and Acute Kidney and Myocardial Injury after Noncardiac Surgery: A Retrospective Cohort Analysis. Anesthesiology. 2017 Jan;126(1):47-65. doi: 10.1097/ALN.0000000000001432.
- Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014 Jul 3;371(1):58-66. doi: 10.1056/NEJMra1214243. No abstract available.
- Ficarra V, Novara G, Secco S, Macchi V, Porzionato A, De Caro R, Artibani W. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol. 2009 Nov;56(5):786-93. doi: 10.1016/j.eururo.2009.07.040. Epub 2009 Aug 4.
- Klatte T, Rossi SH, Stewart GD. Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World J Urol. 2018 Dec;36(12):1943-1952. doi: 10.1007/s00345-018-2309-4. Epub 2018 Apr 30.
- Cho A, Lee JE, Kwon GY, Huh W, Lee HM, Kim YG, Kim DJ, Oh HY, Choi HY. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy. Nephrol Dial Transplant. 2011 Nov;26(11):3496-501. doi: 10.1093/ndt/gfr094. Epub 2011 Mar 15.
- Garofalo C, Liberti ME, Russo D, Russo L, Fuiano G, Cianfrone P, Conte G, De Nicola L, Minutolo R, Borrelli S. Effect of post-nephrectomy acute kidney injury on renal outcome: a retrospective long-term study. World J Urol. 2018 Jan;36(1):59-63. doi: 10.1007/s00345-017-2104-7. Epub 2017 Oct 23.
- Shin S, Han Y, Park H, Chung YS, Ahn H, Kim CS, Cho YP, Kwon TW. Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma. J Vasc Surg. 2013 Oct;58(4):1021-7. doi: 10.1016/j.jvs.2013.02.247. Epub 2013 Apr 13.
- Turan A, Cohen B, Adegboye J, Makarova N, Liu L, Mascha EJ, Qiu Y, Irefin S, Wakefield BJ, Ruetzler K, Sessler DI. Mild Acute Kidney Injury after Noncardiac Surgery Is Associated with Long-term Renal Dysfunction: A Retrospective Cohort Study. Anesthesiology. 2020 May;132(5):1053-1061. doi: 10.1097/ALN.0000000000003109.
- Kim WH, Shin KW, Ji SH, Jang YE, Lee JH, Jeong CW, Kwak C, Lim YJ. Robust Association between Acute Kidney Injury after Radical Nephrectomy and Long-term Renal Function. J Clin Med. 2020 Feb 25;9(3):619. doi: 10.3390/jcm9030619.
- Shin CH, Long DR, McLean D, Grabitz SD, Ladha K, Timm FP, Thevathasan T, Pieretti A, Ferrone C, Hoeft A, Scheeren TWL, Thompson BT, Kurth T, Eikermann M. Effects of Intraoperative Fluid Management on Postoperative Outcomes: A Hospital Registry Study. Ann Surg. 2018 Jun;267(6):1084-1092. doi: 10.1097/SLA.0000000000002220.
- Myles PS, McIlroy DR, Bellomo R, Wallace S. Importance of intraoperative oliguria during major abdominal surgery: findings of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery trial. Br J Anaesth. 2019 Jun;122(6):726-733. doi: 10.1016/j.bja.2019.01.010. Epub 2019 Feb 16.
- Giglio M, Dalfino L, Puntillo F, Brienza N. Hemodynamic goal-directed therapy and postoperative kidney injury: an updated meta-analysis with trial sequential analysis. Crit Care. 2019 Jun 26;23(1):232. doi: 10.1186/s13054-019-2516-4.
- Kellum JA, Ronco C, Mehta RL. Fluid management in acute kidney injury. Int J Artif Organs. 2008 Feb;31(2):94-5. doi: 10.1177/039139880803100203. No abstract available.
- Wu QF, Kong H, Xu ZZ, Li HJ, Mu DL, Wang DX. Impact of goal-directed hemodynamic management on the incidence of acute kidney injury in patients undergoing partial nephrectomy: a pilot randomized controlled trial. BMC Anesthesiol. 2021 Mar 3;21(1):67. doi: 10.1186/s12871-021-01288-8.
- Pancaro C, Shah N, Pasma W, Saager L, Cassidy R, van Klei W, Kooij F, Vittali D, Hollmann MW, Kheterpal S, Lirk P. Risk of Major Complications After Perioperative Norepinephrine Infusion Through Peripheral Intravenous Lines in a Multicenter Study. Anesth Analg. 2020 Oct;131(4):1060-1065. doi: 10.1213/ANE.0000000000004445.
研究記録日
主要日程の研究
研究開始 (予想される)
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
腎細胞がんの臨床試験
-
Sun Yat-sen Universityまだ募集していません子宮頸癌 | 化学療法効果 | ネオアジュバント療法 | Programmed Cell Death 1 Receptor / アンタゴニストと阻害剤
-
Adelphi Values LLCBlueprint Medicines Corporation完了肥満細胞性白血病 (MCL) | 攻撃的な全身性肥満細胞症 (ASM) | SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD) | くすぶり全身性肥満細胞症 (SSM) | 無痛性全身性肥満細胞症 (ISM) ISM サブグループが完全に募集されましたアメリカ
-
National Cancer Institute (NCI)積極的、募集していない低分化型甲状腺がん | 難治性分化型甲状腺がん | 難治性甲状腺癌 | 濾胞性バリアント甲状腺乳頭がん | Tall Cell Variant 甲状腺乳頭がん | 分化型甲状腺がん | 甲状腺濾胞癌 | 甲状腺乳頭癌 | 甲状腺腫瘍細胞癌アメリカ
-
National Cancer Institute (NCI)Exelixis完了再発甲状腺がん | 低分化型甲状腺がん | ステージ I 甲状腺乳頭癌 | II期の甲状腺乳頭癌 | III期の甲状腺乳頭がん | Tall Cell Variant 甲状腺乳頭がん | ステージ I 甲状腺濾胞癌 | II期甲状腺濾胞がん | III期の甲状腺濾胞がん | ステージ IVA 甲状腺濾胞癌 | ステージ IVA 甲状腺乳頭癌 | ステージ IVB 甲状腺濾胞癌 | ステージ IVB 甲状腺乳頭癌 | IVC 期の甲状腺濾胞がん | IVC 期の甲状腺乳頭がん | 甲状腺腫瘍性濾胞癌アメリカ
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)完了低分化型甲状腺がん | 再発性分化型甲状腺がん | 円柱状細胞バリアント甲状腺乳頭癌 | 濾胞性バリアント甲状腺乳頭がん | 転移性甲状腺濾胞癌 | 転移性甲状腺乳頭癌 | 再発甲状腺濾胞癌 | 再発甲状腺乳頭癌 | ステージ III 分化型甲状腺がん AJCC v7 | ステージ III 甲状腺濾胞癌 AJCC v7 | ステージ III 甲状腺乳頭がん AJCC v7 | ステージ IV 甲状腺濾胞癌 AJCC v7 | ステージ IV 甲状腺乳頭癌 AJCC v7 | ステージ IVA 分化型甲状腺がん AJCC v7 | ステージ IVA 甲状腺濾胞癌 AJCC v7 | ステージ IVA 甲状腺乳頭癌 AJCC v7 | ステージ IVB 分化型甲状腺がん... およびその他の条件アメリカ